FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Dr. Doug Woolley: CMS needs to get tough on hospital acquired infections
Comments
Six weeks after discharge is too long to wait to receive payment from an insurer. Our practice receives payment in a month for our patients. Granted, we are not solely a surgical practice, but if we waited 42 days after discharge to get paid by insurance, and then had to send a bill to the patient for the rest and wait for that, we would be in terrible financial shape over the long haul, all for a complication that affects less than 1 in 100 patients. From a patient standpoint, this is a topic that is near and dear to my heart. I have to have many surgeries due to a medical condition. I also have to take prednisone and Imuran, and I always get a post-surgical infection. It does not matter what the surgeon does or what I do; it just always happens, as I have no way to fight off the bacteria other than antibiotics, and there is no antibiotic that kills or prevents everything. Things like this make me afraid that doctors and hospitals will not want to take care of me due to my certain impact on their "numbers." Most hospitals and doctors really want to prevent infections and do a good job at it; financial penalties will not serve to prevent complications. They will serve to hide them and/or prevent the procedures from being done in the first place.
I recently learned of a new application of an old NASA developed technology, this was in the ICT virtual trade show. 2 vendors presented very similar technolgy that virtually eliminated unwanted microbial activity in a clinical setting including MRSA, C-Diff, Noro-virus, even Avian Flu. I was quite impressed. It was AntisepticAir and Air Scrub.
I appreciate the comments from both readers who bring up some interesting points.
To the first comment about accounts receivables. I was referring to orthopaedics and total joint reconstruction. As I had the opportunity to try different options in practice style throughout my career from multispecialty group, to orthopaedic group, to solo, the common refrain was "time to collections" for receivables. It averaged around 90 days and anytime it approached 60 days we were in clover. I saw all kinds of tricks from payers to delay payment in my career; and at the end the best way to get paid was by elctronic submission. None the less the data from CMS, Leapfrog etc. all show a lack of quality results with high readmission rates with our current system which is broken and dysfunctional. This is unacceptable to me as a doctor, taxpayer and patient. If we do not start documenting, this folly and preventable waste will continue; hence the carrot and stick approach.
Additionally we did not all graduate from Lake Woebegone (Garrison Keilor) so there is a bell curve(data) for both doctors and hospitals and I would prefer to slect both from the extreme positive side. Interestingl thes are the few who keep data and routinely take care of the high risk patients with good to excellent results.
Without any information fro your history other than the immunosuppressive drugs; from my own experience and the multiple large series in the literature immunosuppressed TJR patients on active treatment are at an increased risk of infection up to normally 2-3%, but never more than 5%. It could be higher obviously , but far too often doctors, hospitals and companies do not report poor results willingly! Therfore blaming the patient with a 100% infection rate for TJR infection is unacceptable. If there was better data then you would not have to expect that. If your infections are superficial there are multiple causes from different preps, sutures and skin closure techniques to name a few.
Finally pay for performance is coming and it is much better to be way ahead of the cart than catching up to push it. Everyone needs to collect their own data as second hand data from CMS and payers is often flawed. We have the most expensive healthcare system in the free world and yet it is rated 37th (WHO) for our poor access and quality. We can and must do better.
With regards to new technology, I have loved every new toy that money could buy and was most recently one of the vocal supporters for the 4 new ORs with high efficiency scrubbers. I do not remember the brand, but I believe the cost was around $250-500K/OR. How ironic it was that my patients and I were on the receiving end of the plugged dfiltration systems as a result of the construction of the new ORs and scrubbers. Technology is easily defeated by poor human decisions as the cleanest air can't beat contaminated sponges, improperly cleaned OR equipment and poor inspection and maintenance of existing filter systems. New technology is sexy, but almost always expensive. If the foudation technology is placed on is faulty ( and it often is as we all want a silver bullet, it will never be a good return on investment. Unfortunately this is happening far too frequently and is only increasing the exorbitant costs of healtcare in the USA (2,100,000,000,000 for 2009).
I was inspired to research further. At a cost of 50k the heart transplant ward of a leading transplant facility was able to reduce their infection rate by 90%. These are preliminary results at 6 months of an ongoing clinical study as yet not published. I would call that a great bang for the buck.





Hospital acquired infections will continue to be a problem until CMS takes a tough stand that makes hospitals, physicians and surgeons financially responsible for all the costs that accrue from an infection acquired within six weeks of discharge (it likely should be closer to 12 weeks for surgery patients).